PT - JOURNAL ARTICLE AU - Zeinab Esmaeilpour AU - A. Duke Shereen AU - Peyman Ghobadi-Azbari AU - Abhishek Datta AU - Adam J. Woods AU - Maria Ironside AU - Jacinta O’Shea AU - Ulrich Kirk AU - Marom Bikson AU - Hamed Ekhtiari TI - Methodology for tDCS integration with fMRI AID - 10.1101/19006288 DP - 2019 Jan 01 TA - medRxiv PG - 19006288 4099 - http://medrxiv.org/content/early/2019/10/03/19006288.short 4100 - http://medrxiv.org/content/early/2019/10/03/19006288.full AB - Integration of tDCS with fMRI holds promise for investigation the underlying mechanism of stimulation effect. There are 118 published tDCS studies (up to 1st Oct 2018) that used fMRI as a proxy measure of neural activation to answer mechanistic, predictive, and localization questions about how brain activity is modulated by tDCS. FMRI can potentially contribute as: a measure of cognitive state-level variance in baseline brain activation before tDCS; inform the design of stimulation montages that aim to target functional networks during specific tasks; and act as an outcome measure of functional response to tDCS. In this systematic review we explore methodological parameter space of tDCS integration with fMRI. Existing tDCS-fMRI literature shows little replication across these permutations; few studies used comparable study designs. Here, we use a case study with both task and resting state fMRI before and after tDCS in a cross-over design to discuss methodological confounds. We further outline how computational models of current flow should be combined with imaging data to understand sources of variability in responsiveness. Through the case study, we demonstrate how modeling and imaging methodology can be integrated for individualized analysis. Finally, we discuss the importance of conducting tDCS-fMRI with stimulation equipment certified as safe to use inside the MR scanner, and of correcting for image artifacts caused by tDCS. tDCS-fMRI can address important questions on the functional mechanisms of tDCS action (e.g. target engagement) and has the potential to support enhancement of behavioral interventions, provided studies are designed rationally.Competing Interest StatementCUNY has patents on brain stimulation with M. Bikson as inventor. M.Bikson has equity in Soterix Medical Inc. and serves on the scientific advisory boards of Boston Scientific and GlaxoSmithKline None of the remaining authors have potential conflicts of interest to be disclosed.Funding StatementThis work was supported (to MB) National Institutes of Health: NIH-NINDS 1R01NS101362, NIH-NIMH 1R01MH111896, NIH-NCI U54CA137788/U54CA132378, and NIH-NIMH 1R01MH109289. HE received supports from Warren K Family foundation and supported by a NARSAD young investigator grant (27305) from Brain and Behavior Research Foundation for this work. ZE was supported by Iranian Cognitive Sciences and Technologies Council.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableData, list of studies include in the systematic review and/or code used in this study are available in the public domain upon direct request from authors.